Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Zobel

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Cell Reports|May 6, 2026
PARP1-specific inhibitor displays PARP1-detrapping activityKira Schützenhofer, Ellen Laker, Kyle Tsang, et al.
Diabetes|March 14, 2019
Cardiac Autonomic Function Is Associated With Myocardial Flow Reserve in Type 1 DiabetesEmilie H Zobel, Philip Hasbak, Signe A Winther, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 2020
Hyperoxia improves autonomic function in individuals with long-duration type 1 diabetes and macroalbuminuriaJ C Laursen, C S Hansen, M Bordino, et al.
Journal of Diabetes and Its Complications|July 30, 2016
High osteoprotegerin is associated with development of foot ulcer in type 1 diabetesEmilie H Zobel, Bernt J von Scholten, Maria Lajer, et al.
BMJ Open Diabetes Research & Care|September 14, 2021
Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trialEmilie H Zobel, Asger Wretlind, Rasmus S Ripa, et al.
Cardiovascular Diabetology|February 12, 2020
Relation of cardiac adipose tissue to coronary calcification and myocardial microvascular function in type 1 and type 2 diabetesEmilie H Zobel, Regitse Højgaard Christensen, Signe A Winther, et al.
Diabetes, Obesity & Metabolism|August 13, 2021
Liraglutide reduces cardiac adipose tissue in type 2 diabetes: A secondary analysis of the LIRAFLAME randomized placebo-controlled trialIda K B Rasmussen, Emilie H Zobel, Rasmus S Ripa, et al.
Circulation. Cardiovascular Imaging|June 30, 2021
Effect of Liraglutide on Arterial Inflammation Assessed as [<sup>18</sup>F]FDG Uptake in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled TrialRasmus S Ripa, Emilie H Zobel, Bernt J von Scholten, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 12, 2021
Non-invasive assessment of temporal changes in myocardial microvascular function in persons with type 2 diabetes and healthy controlsIda K B Rasmussen, Philip Hasbak, Bernt J von Scholten, et al.
Diabetes Care|January 19, 2023
Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover TrialViktor Rotbain Curovic, Niels Jongs, Marjolein Y A M Kroonen, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Cell Reports|May 6, 2026
PARP1-specific inhibitor displays PARP1-detrapping activityKira Schützenhofer, Ellen Laker, Kyle Tsang, et al.
Diabetes|March 14, 2019
Cardiac Autonomic Function Is Associated With Myocardial Flow Reserve in Type 1 DiabetesEmilie H Zobel, Philip Hasbak, Signe A Winther, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 2020
Hyperoxia improves autonomic function in individuals with long-duration type 1 diabetes and macroalbuminuriaJ C Laursen, C S Hansen, M Bordino, et al.
Journal of Diabetes and Its Complications|July 30, 2016
High osteoprotegerin is associated with development of foot ulcer in type 1 diabetesEmilie H Zobel, Bernt J von Scholten, Maria Lajer, et al.
BMJ Open Diabetes Research & Care|September 14, 2021
Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trialEmilie H Zobel, Asger Wretlind, Rasmus S Ripa, et al.
Cardiovascular Diabetology|February 12, 2020
Relation of cardiac adipose tissue to coronary calcification and myocardial microvascular function in type 1 and type 2 diabetesEmilie H Zobel, Regitse Højgaard Christensen, Signe A Winther, et al.
Diabetes, Obesity & Metabolism|August 13, 2021
Liraglutide reduces cardiac adipose tissue in type 2 diabetes: A secondary analysis of the LIRAFLAME randomized placebo-controlled trialIda K B Rasmussen, Emilie H Zobel, Rasmus S Ripa, et al.
Circulation. Cardiovascular Imaging|June 30, 2021
Effect of Liraglutide on Arterial Inflammation Assessed as [<sup>18</sup>F]FDG Uptake in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled TrialRasmus S Ripa, Emilie H Zobel, Bernt J von Scholten, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 12, 2021
Non-invasive assessment of temporal changes in myocardial microvascular function in persons with type 2 diabetes and healthy controlsIda K B Rasmussen, Philip Hasbak, Bernt J von Scholten, et al.
Diabetes Care|January 19, 2023
Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover TrialViktor Rotbain Curovic, Niels Jongs, Marjolein Y A M Kroonen, et al.
Pageof 4